AbCellera Biologics (ABCL) has released an update.
On February 20, 2024, during its earnings call, the Company will discuss its financial performance for the year ending December 31, 2023, using a corporate presentation. The details provided in the presentation and other documents are for informational purposes and should not be considered part of the formal financial filings under securities laws.
For further insights into ABCL stock, check out TipRanks’ Stock Analysis page.
